| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.26 | 7e-05 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.25 | 0.0001 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.26 | 0.0001 |